Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?

NewsGuard 100/100 Score

In a recent study posted to the medRxiv* preprint server, researchers explored the impact of the coronavirus disease 2019 (COVID-19) pandemic-associated non-pharmaceutical prevention measures on the transmission of 22 infectious diseases in England.

Study: Impact of the COVID-19 pandemic on the circulation of other pathogens in England. Image Credit: Rost9/Shutterstock
Study: Impact of the COVID-19 pandemic on the circulation of other pathogens in England. Image Credit: Rost9/Shutterstock

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Background

The efforts to contain the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the early days of the pandemic before the widespread availability of COVID-19 vaccines consisted of government-initiated lockdowns, mask-wearing, and social distancing measures. Public health communications also strongly encouraged hand-washing.

Studies suggest that apart from limiting the transmission of SARS-CoV-2, these measures could have affected the transmission of other pathogens that are airborne or spread through the fecal-oral route.

About the study

In the present study, the researchers used data from three sources — the United Kingdom (U.K.) Health Security Agency, the Royal College of General Practitioners Research and Surveillance Centre, and the U.K. Office for National Statistics — to analyze the transmission patterns of 22 pathogens in England during the COVID-19 pandemic.

The study investigated the transmission of diseases that spread through aerosolized droplets, direct contact, blood, vectors, and the fecal-oral route. Airborne diseases included chickenpox, measles, mumps, rubella, tuberculosis, influenza, pneumococcal disease, pertussis, strep throat, and scarlet fever.

Herpes simplex virus, methicillin-resistant Staphylococcus aureus (MRSA), urinary tract infections, and skin and subcutaneous tissue infections were the investigated diseases that spread through direct contact. Skin and subcutaneous tissue infections include cellulitis, folliculitis, abscesses, trauma-related infections, and other necrotizing or uncomplicated conditions of the skin and subcutaneous fat that result in erythema, inflammation, and pain.

The diseases transmitted via the fecal-oral route comprised hepatitis E, norovirus, shigellosis, cryptosporidiosis, infectious intestinal diseases, and foodborne diseases. Infectious intestinal diseases typically refer to diseases of the small intestine, stomach, or bowels, such as gastroenteritis, typhoid, and cholera, which cause diarrhea, abdominal pain, and vomiting. The vector-transmitted disease examined in the study was Lyme disease, while the blood-borne disease was hepatitis C.

The transmission patterns of these pathogens were examined in association with COVID-19 preventative measures implemented between March 2020 and February 2022 in the U.K. The major measures include the first and second lockdowns, which began on 23 March and 5 November 2020, respectively. The first vaccination administration and the third lockdown, which occurred on subsequent days (4 and 5 January 2021), were also included in the study.

Results

The results reported a decrease in the cases of all infectious diseases except MRSA, Lyme disease, and hepatitis E after the first lockdown. The authors believe that since MRSA predominantly occurs in hospitals, the surge in MRSA cases during the increased hospitalizations during COVID-19 was logical.

While Lyme disease cases did not show a marked decrease during the first lockdown, the number of cases did decrease during the course of the COVID-19 pandemic. Nine out of 10 airborne diseases and four out of the six diseases transmitted through the fecal-oral route displayed a significant reduction in cases from the time the COVID-19 preventative measures were implemented. Tuberculosis was the exception in airborne diseases, which the authors believe could be explained due to delayed diagnoses during lockdowns, or tuberculosis co-infections with COVID-19.

Despite concerns that interruption of routine vaccinations would cause a resurgence of vaccine-preventable infections, diseases such as mumps, measles, rubella, pneumococcal disease, influenza, and pertussis remained suppressed even after restrictions were lifted. However, non-vaccine preventable diseases such as scarlet fever, strep throat, and chickenpox (vaccination not routinely provided in the U.K.) showed a surge after COVID-19 preventative measures were discontinued.

With decreased human interactions and lockdowns resulting in reduced exposure to the environment and common pathogens, concerns were expressed about increased disease outbreaks due to reduced overall immunity. However, the study reported that only four of the 22 examined diseases displayed an increase in transmission beyond the pre-COVID-19 levels. These were chickenpox, skin and subcutaneous infections, herpes simplex, and infectious intestinal diseases.

Conclusions

Overall, the study indicated that COVID-19 non-pharmaceutical mitigation strategies such as lockdowns, social distancing, and hand-washing significantly reduced the spread of other infectious pathogens, especially those transmitted through aerosolized droplets and the fecal-oral route.

Lack of exposure to common pathogens during lockdowns and other social-distancing measures did not reduce the overall immunity and result in disease outbreaks after these measures were discontinued, except for chickenpox, herpes simplex, and skin and intestinal infections. However, whether the increase in the incidence of these four diseases is connected to COVID-19 measures has not been investigated.

Vaccine-preventable diseases remained suppressed even after COVID-19 restrictions were lifted. Still, diseases such as chickenpox surged, highlighting the need to incorporate chickenpox vaccines into the routine vaccination program in the U.K.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 15 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Dr. Chinta Sidharthan

Written by

Dr. Chinta Sidharthan

Chinta Sidharthan is a writer based in Bangalore, India. Her academic background is in evolutionary biology and genetics, and she has extensive experience in scientific research, teaching, science writing, and herpetology. Chinta holds a Ph.D. in evolutionary biology from the Indian Institute of Science and is passionate about science education, writing, animals, wildlife, and conservation. For her doctoral research, she explored the origins and diversification of blindsnakes in India, as a part of which she did extensive fieldwork in the jungles of southern India. She has received the Canadian Governor General’s bronze medal and Bangalore University gold medal for academic excellence and published her research in high-impact journals.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Sidharthan, Chinta. (2023, May 15). Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?. News-Medical. Retrieved on April 19, 2024 from https://www.news-medical.net/news/20221025/Did-COVID-19-mitigation-measures-in-the-United-Kingdom-impact-the-transmission-of-other-infectious-diseases.aspx.

  • MLA

    Sidharthan, Chinta. "Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?". News-Medical. 19 April 2024. <https://www.news-medical.net/news/20221025/Did-COVID-19-mitigation-measures-in-the-United-Kingdom-impact-the-transmission-of-other-infectious-diseases.aspx>.

  • Chicago

    Sidharthan, Chinta. "Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?". News-Medical. https://www.news-medical.net/news/20221025/Did-COVID-19-mitigation-measures-in-the-United-Kingdom-impact-the-transmission-of-other-infectious-diseases.aspx. (accessed April 19, 2024).

  • Harvard

    Sidharthan, Chinta. 2023. Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?. News-Medical, viewed 19 April 2024, https://www.news-medical.net/news/20221025/Did-COVID-19-mitigation-measures-in-the-United-Kingdom-impact-the-transmission-of-other-infectious-diseases.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Annual COVID-19 vaccine proves to be a wise investment for personal health and pocketbook